Marine Algal Biotechnology and Applications—2nd Edition
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Biotechnology Related to Drug Discovery or Production".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 10
Special Issue Editor
Interests: biotechnologies; microbiology; biological sciences; sustanaibility; green chemicals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Following the success of the Special Issue "Marine Algal Biotechnology and Applications”, (https://www.mdpi.com/journal/marinedrugs/special_issues/B213496Y3D), we are delighted to announce the second edition.
The scientific interest in marine algae has grown considerably due to the possibility of synthesizing high-value molecules for various applications across many fields, such as nutraceuticals, pharmaceutics, cosmetics, and animal nutrition. Furthermore, algae can be used in environmentally friendly biotechnological applications, i.e., water treatments, biofuels, and biomaterial production.
The greatest challenges in the development of biotechnology and applications using algae involve the discovery of new species and the optimization, feasibility, and cost-effectiveness of biotechnological processes.
This Special Issue will showcase high-quality research papers and reviews, to enhance our knowledge of this topic. We invite you to submit innovative studies on new microalgal and algal species and biotechnological processes to facilitate the production of high-value compounds for applications in healthcare or cosmetic fields.
Dr. Patrizia Casella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microalgae
- seaweed
- alternative protein sources
- fatty acids
- high-value compounds
- biofuels
- biomaterials
- sustainability
- circularity
- biotechnologies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
